Answers are grounded in this paper and cite their sources.
A new, catalytic enantioselective route to 3-arylindan-1-ones, versatile intermediates for the synthesis of a number of bioactive and pharmaceutically interesting molecules, was developed by exploiting the chiral dirhodium(II) complex-catalyzed intramolecular C-H insertion reaction of α-diazo-β-ketoesters as a key step.Dirhodium(II) tetrakis[N-phthaloyl-(S)-tert-leucinate],Rh 2 (S-PTTL) 4 , proved to be the catalyst of choice for this process, providing
No takes yet. Share an insight, caveat, or question.
Hashimoto et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: